GlassScriptPhysician profile
Luis Colon
NPI 1366647141
$213.19
in general payments reported to CMS, 2019-2025
5 companies · $21.34 in 2025
The $21.34 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $76.76 · 2023: $45.44 · 2024: $19.65 · 2025: $21.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $76.76 | 2020 | |
| Mylan Specialty L.P. | $50.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.44 | 2023 | Opsumit, Uptravi, Xarelto |
| Dexcom, INC. | $21.34 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $19.65 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.